York, U.K. 7 October 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high-quality and effective rapid tests, notes that a judgement in relation to the
York, U.K. 7 October 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high-quality and effective rapid tests, notes that a judgement in relation to the
Royal Mail will take on the striking union. This is by dismantling a “groundbreaking agreement” to protect jobs, conditions and wages that was signed nine years ago when the company
After 115,000 Royal Mail workers declared they would strike in less than a fortnight, Britain’s postal service is now paralysed with no delivery of letters or prescription medicines.
Purchase of 10m Abingdon Health Simply Test COVID-19 antigen tests; subject to Taiwan FDA approval of test
York, U.K. 30 May 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces that it has signed a Testing
Significant contract signed to manufacture lateral flow device components
Focused on the on development and commercialisation of Lyme disease lateral flow self-test
Tower Resources plc (the “Company” or “Tower” (TRP.L, TRP LN), the AIM-listed oil and gas company with a focus on Africa, is pleased to provide an update on activity in
Completion of Technical Transfer to full-scale manufacture and initial orders for Vatic KnowNowTM test
Technical transfer completed mid-December as planned
Due to the tsunami of omicrons that have swept through many areas of our daily lives, nearly twice as many people were diagnosed as Covid-19 over the past seven days